NasdaqCM:ATYRBiotechs
How a Surge in Bearish Options Activity at aTyr Pharma (ATYR) Has Changed Its Investment Story
On September 5, 2025, aTyr Pharma Inc saw unusually high bearish put option volume, with the Put/Call ratio rising to 1.55 and at-the-money implied volatility increasing by nearly six points as the company approaches its anticipated November 6 earnings report.
This concentration of speculative bearish bets highlights heightened caution among investors, marking a period of intensified scrutiny for aTyr ahead of its key financial update.
Next, we’ll explore how the surge in bearish options...